Emerging drugs for the treatment of perennial allergic rhinitis

Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report

(2015) N. G. Papadopoulos et al.   ALLERGY

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

(2015) J. Bousquet et al.   ALLERGY

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

(2015) G. Senti et al.   ALLERGY

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

(2015) O. Boyman et al.   ALLERGY

Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: Results from a noninterventional study

(2015) Ludger Klimek et al.   ALLERGY AND ASTHMA PROCEEDINGS

Intranasal Spray Medications for Maintenance Therapy of Allergic Rhinitis

(2015) William E. Berger et al.   American Journal of Rhinology & Allergy

SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

(2015) Holger Mosbech et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects

(2015) P. Couroux et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Toll-like receptors as targets for allergen immunotherapy

(2015) Zahra Aryan et al.   Current Opinion in Allergy and Clinical Immunology

Allergy immunotherapy in reducing healthcare cost

(2015) Linda Cox   Current Opinion in Otolaryngology & Head and Neck Surgery

Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma

(2015) Go Takahashi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The discovery and development of omalizumab for the treatment of asthma

(2015) Amelia Licari et al.   Expert Opinion on Drug Discovery

Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps

(2015) Jean Bousquet et al.   EXPERT OPINION ON PHARMACOTHERAPY

From IgE to clinical trials of allergic rhinitis

(2015) Giorgio Ciprandi et al.   Expert Review of Clinical Immunology

Current controversies and challenges in allergic rhinitis management

(2015) David Price et al.   Expert Review of Clinical Immunology

International consensus on allergy immunotherapy

(2015) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergic Rhinitis

(2015) Lisa M. Wheatley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis

(2015) Danilo Di Bona et al.   JAMA Internal Medicine

House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies

(2015) Moisés A. Calderón et al.   Journal of Allergy and Clinical Immunology-In Practice

Intralymphatic immunotherapy

(2015) Gabriela Senti et al.   World Allergy Organization Journal

New intranasal formulations for the treatment of allergic rhinitis

(2014) Eli O. Meltzer et al.   ALLERGY AND ASTHMA PROCEEDINGS

Current Allergic Rhinitis Experiences Survey (CARES): Consumers' awareness, attitudes and practices

(2014) Leonard M. Fromer et al.   ALLERGY AND ASTHMA PROCEEDINGS

Current Allergic Rhinitis Experiences Survey (CARES): Health-care practitioners' awareness, attitudes and practices

(2014) Michael S. Blaiss et al.   ALLERGY AND ASTHMA PROCEEDINGS

Role of prostaglandin D2and CRTH2 blockade in early- and late-phase nasal responses

(2014) Y. Shiraishi et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Allergy immunotherapy

(2014) Cheryl S. Hankin et al.   Current Opinion in Allergy and Clinical Immunology

Current recommendations and emerging options for the treatment of allergic rhinitis

(2014) Amelia Licari et al.   Expert Review of Clinical Immunology

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs

(2014) Ludger Klimek et al.   Expert Review of Clinical Immunology

A New Era of Targeting the Ancient Gatekeepers of the Immune System: Toll-Like Agonists in the Treatment of Allergic Rhinitis and Asthma

(2014) Zahra Aryan et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Immunotherapy: What lies beyond

(2014) Thomas B. Casale et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab in Children

(2014) Amelia Licari et al.   PEDIATRIC DRUGS

Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

(2014) Sophia Tsabouri et al.   Journal of Allergy and Clinical Immunology-In Practice

Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective?

(2014) Harold S. Nelson   Journal of Allergy and Clinical Immunology-In Practice

Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis

(2014) William E. Berger et al.   Journal of Allergy and Clinical Immunology-In Practice

New treatments for allergen immunotherapy

(2014) Mübeccel Akdis   World Allergy Organization Journal

Mechanisms and potential therapeutic targets in allergic inflammation: recent insights

(2013) S. von Gunten et al.   ALLERGY

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis

(2013) Philippe Bareille et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Effectiveness of montelukast in pediatric patients with allergic rhinitis

(2013) Ozge Yilmaz et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion

(2013) William T. Barchuk et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

(2013) A. Wesley Burks et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis

(2013) Norbert Krug et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pharmacology of Antihistamines

(2013) Diana S Church et al.   World Allergy Organization Journal

The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis

(2012) J. Mallol et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

(2012) P. W. Hellings et al.   ALLERGY

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

(2012) J. Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Local allergic rhinitis: Concept, pathophysiology, and management

(2012) Carmen Rondón et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review

(2011) U. Nurmatov et al.   ALLERGY

Use of Montelukast Alone or in Combination with Desloratadine or Levocetirizine in Patients with Persistent Allergic Rhinitis

(2011) Maciej Ciebiada et al.   American Journal of Rhinology & Allergy

Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America

(2011) C. H. Katelaris et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey

(2011) Giorgio Ciprandi et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Efficacy and Tolerability of Two Novel H1/H3 Receptor Antagonists in Seasonal Allergic Rhinitis

(2011) Peter Daley-Yates et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Histamine and H1-antihistamines: Celebrating a century of progress

(2011) F. Estelle R. Simons et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms

(2011) Jeffrey R. Stokes et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Risk of first-generation H1-antihistamines: a GA2LEN position paper

(2010) M. K. Church et al.   ALLERGY

Allergic rhinitis: Direct and indirect costs

(2010) Michael S. Blaiss   ALLERGY AND ASTHMA PROCEEDINGS

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

(2010) Jan L. Brożek et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effects of omalizumab on markers of inflammation in patients with allergic asthma

(2009) S. Holgate et al.   ALLERGY

Unmet needs in severe chronic upper airway disease (SCUAD)

(2009) Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously

(2009) Wolfgang Kamin et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma

(2008) M. V. Kopp et al.   CLINICAL AND EXPERIMENTAL ALLERGY